S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
OTCMKTS:BLUSF

BELLUS Health (BLUSF) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$6.46
$14.51
52-Week Range
N/A
Volume
3.45 million shs
Average Volume
39,610 shs
Market Capitalization
$2.35 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BLUSF stock logo

About BELLUS Health Stock (OTCMKTS:BLUSF)

BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

BLUSF Stock News Headlines

Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
Natura &Co Holding SA ADR NTCO
Raymond R. Blush
BELLUS Health: Q1 Earnings Insights
Where BELLUS Health Stands With Analysts
Secret Bull Market Starts in This Unusual Sector
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
What's Going On With BELLUS Health's Stock Today?
See More Headlines
Receive BLUSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/08/2019
Today
4/19/2024

Industry, Sector and Symbol

Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:BLUSF
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
$-7,010,000.00
Net Margins
-49,910.34%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$30,000.00
Book Value
$0.25 per share

Miscellaneous

Free Float
N/A
Market Cap
$2.35 billion
Optionable
Not Optionable
Beta
1.55
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Roberto Bellini
    President, Chief Executive Officer & Director
  • François Desjardins
    Vice President-Finance
  • Denis Garceau
    Senior Vice President-Drug Development
  • Tony Matzouranis
    Vice President-Business Development
  • Sébastien Roy
    Secretary

BLUSF Stock Analysis - Frequently Asked Questions

How were BELLUS Health's earnings last quarter?

BELLUS Health Inc (OTCMKTS:BLUSF) posted its quarterly earnings data on Wednesday, May, 8th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.01. The business earned $0.01 million during the quarter. BELLUS Health had a negative trailing twelve-month return on equity of 48.37% and a negative net margin of 49,910.34%.

This page (OTCMKTS:BLUSF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners